Skip to main content
. 2022 Oct 24;93(12):1827–1847. doi: 10.1002/JPER.22-0069

TABLE 3.

Characteristics of included articles on the topic of maxillary sinus floor augmentation

Authors

1. Setting(s)

2. Country(ies)

RCT Design Protocol for sinus floor elevation Biologic Material Final Number of Participants Final number of interventions Healing Time (months) Method(s) for assessment of primary outcomes Main findings from primary outcomes
Barros Mourão et al. (2019)

1. University

2. Brazil

Split‐mouth LA: Osteotomy performed with Piezoelectric. Resorbable membrane between the material and the Schneiderian membrane BDGF CaP 10 10 6 CBCT BDGF does not improve bone repair when associated with calcium phosphate in MSFA procedures
None CaP 10
Bettega et al. (2009)

1. Private practice

2. France

Split‐mouth LA: not specified PRP AB (iliac crest) 18 18 12 CT and histology PRP does not provide any further benefit for bone healing
None AB (iliac crest) 18
Boyne et al. (2005)

1. University

2. USA

Parallel‐group LA: Osteotomy performed with a bur and the lateral bony wall was removed BMP‐2 (0.75mg/mL) ACS 18 18 4 CT and histology BMP‐2 is safe and effective to induce bone formation in maxillary sinus floor elevation procedures to enable implant placement
BMP‐2 (1.5mg/dl) ACS 17 17
None AB and/or ALL 13 13
Cho et al. (2020)

1. University

2. South Korea

Double‐center parallel‐arms CA: Special drilling system with hydraulic system to lift‐up the membrane PRF None 20 20 12 CBCT PRF provided superior support for the elevated sinus membrane
None None 20 20
Froum et al. (2013) (A)

1. University

2. USA

Split‐mouth LA: Rotatory bur or piezoelectric for osteotomy. PDGF DBBM 24 24 4‐5 or 7‐9 Histology More rapid formation of vital bone with the addition of rhPDGF may allow for earlier implant placement
None DBBM 24
Froum et al. (2013)(B)

1. University

2. USA

Split‐mouth LA: Osteotomy performed with rotary bur or piezoelectric BMP‐2/ACS (8.4mg and 5.6 mL) ALL 21 10 6 to 9 Histology The group with higher dose of rhBMP‐2 combined with ALL had more newly formed bone and less residual ALL particles when compared to the group with the lower dose combined with ALL and to the control group
BMP‐2/ACS (4.2mg and 2.8 mL) ALL 11
None ALL 11
Kim et al. (2015)

1. University

2. South Korea

Multi‐center parallel‐arm LA: not specified BMP‐2 (1mg/mL) HA 65 65 3 Histology The use of BMP‐2 is safe, effective and accelerates bone formation in the early stages of healing after MSFA
None DBBM 62 62
Nizam et al. (2018)

1. University

2. Turkey

Split‐mouth LA: Osteotomy performed with rotatory burs. Resorbable membrane adapted to the sinus wall PRF DBBM 13 13 6 Histology RF in ABBM does not improve the amount of regenerated bone or the amount of the graft integrated into the newly formed bone
None DBBM 13
Pichotano et al. (2019)

1. University

2. Brazil

Split‐mouth LA: Osteotomy performed with rotatory burs. Resorbable membrane adapted to the sinus wall L‐PRF DBBM 12 12 4 (test) 8 (control) CBCT, histology and RFA The addition of L‐PRF to DBBM for MSFA allows early implant placement with increased new bone formation than ABBM alone after 8 months of healing
None DBBM 12
Triplett et al. (2009)

1. University

2. USA

Multi‐center parallel‐arm LA: Osteotomy performed with a bur and the lateral bony wall was removed BMP‐2 (1.5mg/dL) ACS 58 58 6 CT and histology BMP‐2 is safe and effective in MSFA with no marked differences in terms of newly bone formation. Vertical bone gain was superior for the control group.
None AB 69 69
Wiltfang et al. (2003)

1. University

2. Germany

Parallel arms LA: not specified PRP TCP 22 22 6 Histology PRP does not significantly contribute to bone regeneration in MSFA
None TCP 23 23
Zhang et al. (2012)

1. University

2. China

Parallel arms LA: Osteotomy prepared for access. PRF DBBM 5 6 6 Histology PRF does not contribute to bone regeneration in MSFA
None DBBM 5 5
None DBBM 22

Abbreviations: PRF, platelet‐rich fibrin; PRP, platelet‐rich plasma; L‐PRF, leucocyte platelet‐rich fibrin; CBCT, cone beam computed tomography; FDBA, freeze‐dried bone allograft; CSH, calcium sulfate hemihydrate; EMD, enamel matrix derivative; DBBM, deproteinized bovine bone mineral; BDGF, blood‐derived growth factors; AB, autologous bone; ALL, allogenic bone; ACS, absorbable collagen sponge; PRGF, plasma rich in growth factors; LA, lateral‐wall approach; CA, crestal approach; CaP, calcium phosphate; TCP, tricalcium phosphate; RFA, resonance frequency analysis; MSFA, maxillary sinus floor augmentation.